Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.40 per share a year ago.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: November 1 at 5:14 p.m. EDT ...

OMGA has 36-month beta value of 1.84. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for OMGA is 20.45M ...

The 36-month beta value for OMGA is also noteworthy at 1.85. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 ...

Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Free Report)’s share price dropped 0.9% on Thursday .The stock traded as low as $1.08 and last traded at $1.12. Approximately 156,117 shares changed ...